Premium
DT‐02‐05: MARKVCID PHASE II: PRIORITIZED CANDIDATE SMALL VESSEL VCID BIOMARKERS SELECTED FOR INDEPENDENT MULTI‐SITE TESTING AND VALIDATION
Author(s) -
Corriveau Roderick A.,
Mcgavern Linda,
Albert Marilyn S.,
Arfanakis Konstantinos,
Arvind Caprihan,
DeCarli Charlie S.,
Fornage Myriam,
Helmer Karl G.,
Jicha Gregory A.,
Kashani Amir H.,
Kramer Joel H.,
Lu Hanzhang,
Ringman John M.,
Rosenberg Gary A.,
Schneider Julie A.,
Schwab Kristin,
Seshadri Sudha,
Tracy Russell,
Wang Danny JJ.,
Wilcock Donna M.,
Greenberg Steven M.
Publication year - 2018
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2018.07.014
Subject(s) - biomarker , dementia , medicine , clinical trial , vascular dementia , biomarker discovery , bioinformatics , pathology , disease , biology , proteomics , gene , biochemistry